Suspected quality defect of the medicinal product resulting from the use of an excipient linked to a batch with an out-of-specification active substance content, which may lead to incorrect dosing of vitamin D. Potential effects: lack of efficacy or adverse effects related to overdose.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batch 200Q046, check the batch number on the packaging, and return the medicine to a pharmacy if you have it; in case of any worrying symptoms after use, contact a doctor.
The Chief Pharmaceutical Inspector withdrew batch 200Q046 of Vigantol from the market throughout the country, granted the decision immediate enforceability, and obliged the marketing authorisation hol...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related